Replies to post #75486 on MMRGlobal, Inc. (fka MMRF)

[Ambrosia]

Yes it is and there should be plenty more where that came from.

[stockmasterflash]

Is the stock a buy

The company spends $3.5 million per year on lawyers. It loses over $1 million per quarter. It pays it's CEO and CFO over $1 million per year in total compensation.

Product

1 year after the national retail rollout, the product is only available on Walgreens website, but not in Walgreens stores. It is available nowhere else on the internet and in no other stores. Dollar value of sales is in the low 5 figures per quarter.

Licensing.

Only client appears to be Celgene and they paid their final milestone payment last quarter. MMRF is dropping hints it is intending to sell the biotech portfolio that it bought from a bankrupt biotech company after no other companies showed any interest at all

Lawsuits

$30 million SCM lawsuit keeps getting thrown out of court. Motion to dismiss yet again is heard this week

3 lawsuits against Allscripts, WebMD, and Quest resulted in 2 key foundation patents being invalidated and MMRF ordered to pay court costs of the defendants. Yesterday the Judge ordered MMRF to explain why it should not pay legal fees too. MMRF has appealed, but in a bizzare twist, also filed to delay the appeal. Most likely because it is completely out of cash.

Allscripts has a separate case at USPTO proactively seeking invalidation of one of the patents.

*** Conflicts of interest ***

The company's CEO and CFO are the only ones certifying financial controls to protect shareholders from management. A member of the audit committee recently resigned.

Currently the CEO is by far the largest shareholder. In the event of a reverse split, shareholders would be wiped out. The CEO would remain majority holder.

The CEO's personal, private company is the company's secured lender. In the event of a bankruptcy, shareholders would be wiped out. The CEO's personal company would get the patents and control over stock in the new company.

LOL, yeah, a company with no sales, huge debt, huge insider payments, huge legal bills and giant conflicts of interest? Look at the chart. If it was shortable, this one is a no brainer short.